the company invested $475 million to purchase its 333,000-square-foot plant in Greenville, North Carolina. Catalent is in the midst of a $16.5 billion merger with Novo Holdings, Novo Nordisk’s ...

Nipro’s products are key to the supply chain of other life sciences companies that produce injectable products, such as those manufactured by Novo Nordisk ... its footprint and offering high-end ...

Over the last couple of years, Danish company Novo Nordisk (NYSE: NVO) has evolved from a relatively obscure pharmaceutical business to perhaps the biggest rising star in healthcare. The company's ...

Novo Nordisk continues to witness strong growth across its portfolio of diabetes and obesity care medications. The company's tailwinds include expanded indications and new geographic markets.

With nearly $14 billion sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO). A Scandinavian economic behemoth ...

The world’s largest philanthropic fund that ultimately controls Novo Nordisk A/S will ramp up its investments outside of Denmark after cashing in on the weight-loss drug boom. The Novo Nordisk ...